Company Vicamed Srl with Fiscal Code 31727000
recorded a turnover of 2024 of
126.884,
with a net profit of
8.160
and having an average number of employees of
1.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Vicamed Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
46.258
44.129
46.733
69.274
78.405
85.651
89.820
92.468
111.711
126.884
Total Income - EUR
46.272
44.129
46.733
69.275
78.405
87.718
101.227
92.468
111.711
126.884
Total Expenses - EUR
37.359
37.901
37.914
47.359
65.982
73.197
92.045
81.247
85.077
114.917
Gross Profit/Loss - EUR
8.913
6.228
8.819
21.916
12.423
14.521
9.183
11.221
26.634
11.967
Net Profit/Loss - EUR
7.525
5.787
8.049
21.223
11.639
13.665
8.284
10.295
25.517
8.160
Employees
0
2
0
0
0
0
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 14.2%, from 111.711 euro in the year 2023, to 126.884 euro in 2024.
The Net Profit decreased by -17.214 euro, from 25.517 euro in 2023, to 8.160 in the last year.
Check the financial reports for the company - Vicamed Srl
Financial Rating - VICAMED SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Vicamed Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Vicamed Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Vicamed Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
18.126 euro in 2024 which includes Inventories of
821 euro, Receivables of
12.330 euro and cash availability of
4.975 euro.
The company's Equity was valued at
52.253 euro, while total Liabilities amounted to
57.236 euro.
Equity increased by 8.160 euro, from 44.341 euro in 2023, to 52.253 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Vicamed Srl